Experienced in Disseminated Intravascular Coagulation
Experienced in Disseminated Intravascular Coagulation
Miemachi, JP 

Overview

Tomoaki Ikeda practices in Miemachi, Japan. Mr. Ikeda is rated as an Experienced expert by MediFind in the treatment of Disseminated Intravascular Coagulation. His top areas of expertise are Intrauterine Growth Restriction, Toxic Shock Syndrome, Peripartum Cardiomyopathy, Hysterectomy, and Lymphadenectomy.

His clinical research consists of co-authoring 337 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Disseminated Intravascular Coagulation.

Gender
Male

Locations

Miemachi, Japan
Other Locations
Tokyo, Japan
Tsu, Japan
Shinjuku, 1620844, Japan
Minamata, Japan
Yamagata, 9900031, Japan
Musashino, 1808602, Japan
Osaka, Japan
Course Of Medical And Dental Sciences, Nagasaki, Japan
Sendai, 9838551, Japan
Suita, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ikeda's expertise for a condition
ConditionClose
    View All 15 Advanced Conditions
    View All 88 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile